Menu

Experience

Rena Kaminsky

    • Neurocrine Partners With Takeda to Address Psychiatric Disorders 


    • Zai Lab Product Commercialization Collaboration with Regeneron 


    • Fate Therapeutics Licensing and Platform Collaboration with Janssen Biotech 


    • Selecta Biosciences – $74 Million IPO 


    • FibroGen Closes Largest Biotech IPO in 12 Years 


    • NewLink Genetics Signs $1 Billion Deal with Genentech for Cancer Drug Research & Development 


    • MyoKardia Collaboration with Sanofi 


    • Two Independent Billion-Dollar Life Sciences Collaborations 


    • Depomed $240 Million Diabetes Drug Sale to PDL BioPharma 


    • FORMA Therapeutics $200M Strategic Collaboration Deal with Celgene 


Contact us

Back to top

© 2021 Cooley LLP and Cooley (UK) LLP. All rights reserved.

Cooley® is a registered service mark of Cooley LLP in the United States and European Union as well as certain other jurisdictions.